S&P 500   3,286.77 (+0.32%)
DOW   28,835.44 (+0.39%)
QQQ   222.16 (+0.32%)
AAPL   327.40 (+3.06%)
FB   222.30 (+2.07%)
MSFT   167.23 (+1.07%)
GOOGL   1,455.85 (+0.37%)
AMZN   1,863.22 (+0.54%)
CGC   23.98 (+0.25%)
NVDA   244.77 (-1.29%)
BABA   210.35 (+0.06%)
MU   55.92 (-0.97%)
GE   12.88 (+9.80%)
TSLA   573.22 (+1.11%)
AMD   46.63 (-7.72%)
ACB   1.98 (+0.51%)
F   8.87 (-1.11%)
NFLX   344.03 (-1.29%)
PRI   121.22 (+0.48%)
DIS   137.07 (-0.94%)
GILD   64.46 (+0.16%)
S&P 500   3,286.77 (+0.32%)
DOW   28,835.44 (+0.39%)
QQQ   222.16 (+0.32%)
AAPL   327.40 (+3.06%)
FB   222.30 (+2.07%)
MSFT   167.23 (+1.07%)
GOOGL   1,455.85 (+0.37%)
AMZN   1,863.22 (+0.54%)
CGC   23.98 (+0.25%)
NVDA   244.77 (-1.29%)
BABA   210.35 (+0.06%)
MU   55.92 (-0.97%)
GE   12.88 (+9.80%)
TSLA   573.22 (+1.11%)
AMD   46.63 (-7.72%)
ACB   1.98 (+0.51%)
F   8.87 (-1.11%)
NFLX   344.03 (-1.29%)
PRI   121.22 (+0.48%)
DIS   137.07 (-0.94%)
GILD   64.46 (+0.16%)
S&P 500   3,286.77 (+0.32%)
DOW   28,835.44 (+0.39%)
QQQ   222.16 (+0.32%)
AAPL   327.40 (+3.06%)
FB   222.30 (+2.07%)
MSFT   167.23 (+1.07%)
GOOGL   1,455.85 (+0.37%)
AMZN   1,863.22 (+0.54%)
CGC   23.98 (+0.25%)
NVDA   244.77 (-1.29%)
BABA   210.35 (+0.06%)
MU   55.92 (-0.97%)
GE   12.88 (+9.80%)
TSLA   573.22 (+1.11%)
AMD   46.63 (-7.72%)
ACB   1.98 (+0.51%)
F   8.87 (-1.11%)
NFLX   344.03 (-1.29%)
PRI   121.22 (+0.48%)
DIS   137.07 (-0.94%)
GILD   64.46 (+0.16%)
S&P 500   3,286.77 (+0.32%)
DOW   28,835.44 (+0.39%)
QQQ   222.16 (+0.32%)
AAPL   327.40 (+3.06%)
FB   222.30 (+2.07%)
MSFT   167.23 (+1.07%)
GOOGL   1,455.85 (+0.37%)
AMZN   1,863.22 (+0.54%)
CGC   23.98 (+0.25%)
NVDA   244.77 (-1.29%)
BABA   210.35 (+0.06%)
MU   55.92 (-0.97%)
GE   12.88 (+9.80%)
TSLA   573.22 (+1.11%)
AMD   46.63 (-7.72%)
ACB   1.98 (+0.51%)
F   8.87 (-1.11%)
NFLX   344.03 (-1.29%)
PRI   121.22 (+0.48%)
DIS   137.07 (-0.94%)
GILD   64.46 (+0.16%)
Log in

OTCMKTS:PHGUF - Pharming Group Stock Price, Forecast & News

$1.50
0.00 (0.00 %)
(As of 01/29/2020 12:09 PM ET)
Today's Range
$1.46
Now: $1.50
$1.54
50-Day Range
$1.50
MA: $1.70
$1.81
52-Week Range
$0.79
Now: $1.50
$1.82
Volume8,057 shs
Average Volume5,158 shs
Market Capitalization$868.53 million
P/E RatioN/A
Dividend YieldN/A
Beta1.31
Pharming Group N.V., a specialty pharmaceutical company, develops and produces human therapeutic proteins for the treatment of rare diseases and unmet medical needs. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the treatment of angioedema attacks in patients with acute hereditary angioedema (HAE) in Europe, the United States, Israel, European Union countries, Norway, Iceland, and Liechtenstein. Read More…

Industry, Sector and Symbol

Industry Tobacco products
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:PHGUF
CUSIPN/A
CIKN/A
Phone31-71-524-7400

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$101.24 million

Profitability

Miscellaneous

Employees183
Market Cap$868.53 million
Next Earnings DateN/A
OptionableNot Optionable

Receive PHGUF News and Ratings via Email

Sign-up to receive the latest news and ratings for PHGUF and its competitors with MarketBeat's FREE daily newsletter.


Pharming Group (OTCMKTS:PHGUF) Frequently Asked Questions

What is Pharming Group's stock symbol?

Pharming Group trades on the OTCMKTS under the ticker symbol "PHGUF."

How were Pharming Group's earnings last quarter?

Pharming Group (OTCMKTS:PHGUF) posted its quarterly earnings data on Thursday, March, 5th. The biotechnology company reported $0.05 EPS for the quarter, beating the consensus estimate of $0.04 by $0.01. View Pharming Group's Earnings History.

Has Pharming Group been receiving favorable news coverage?

Media stories about PHGUF stock have trended very negative on Wednesday, according to InfoTrie. The research group rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Pharming Group earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned news stories about the biotechnology company a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an impact on the stock's share price in the near term. View News Stories for Pharming Group.

Who are some of Pharming Group's key competitors?

What other stocks do shareholders of Pharming Group own?

Who are Pharming Group's key executives?

Pharming Group's management team includes the folowing people:
  • Dr. Sijmen de Vries M.D., MBA, Chairman of Management Board & CEO (Age 60)
  • Mr. Robin Wright BA (Oxon), FCA., CFO & Member of Management Board (Age 55)
  • Dr. Bruno M. L Giannetti, COO & Member of Management Board (Age 67)
  • Dr. Pericles Calias, Chief Scientific Officer (Age 51)
  • Ms. Anne-Marie de Groot, Sr. VP of Organisational Devel. (Age 38)

How do I buy shares of Pharming Group?

Shares of PHGUF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Pharming Group's stock price today?

One share of PHGUF stock can currently be purchased for approximately $1.50.

How big of a company is Pharming Group?

Pharming Group has a market capitalization of $868.53 million and generates $101.24 million in revenue each year. Pharming Group employs 183 workers across the globe.View Additional Information About Pharming Group.

What is Pharming Group's official website?

The official website for Pharming Group is http://www.pharming.com/.

How can I contact Pharming Group?

Pharming Group's mailing address is Darwinweg 24, Leiden P7, 2333 CR. The biotechnology company can be reached via phone at 31-71-524-7400 or via email at [email protected]


MarketBeat Community Rating for Pharming Group (OTCMKTS PHGUF)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  156 (Vote Outperform)
Underperform Votes:  196 (Vote Underperform)
Total Votes:  352
MarketBeat's community ratings are surveys of what our community members think about Pharming Group and other stocks. Vote "Outperform" if you believe PHGUF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PHGUF will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/29/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel